1,903 Shares in Agilent Technologies, Inc. (NYSE:A) Acquired by Triad Wealth Partners LLC

Triad Wealth Partners LLC bought a new position in shares of Agilent Technologies, Inc. (NYSE:A) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,903 shares of the medical research company’s stock, valued at approximately $256,000.

Other large investors have also added to or reduced their stakes in the company. CKW Financial Group boosted its holdings in Agilent Technologies by 114.9% in the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock worth $25,000 after acquiring an additional 100 shares in the last quarter. Global X Japan Co. Ltd. boosted its holdings in Agilent Technologies by 161.1% in the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock worth $25,000 after acquiring an additional 116 shares in the last quarter. Ashton Thomas Securities LLC bought a new position in Agilent Technologies in the third quarter worth approximately $31,000. Hanson & Doremus Investment Management boosted its holdings in Agilent Technologies by 66.5% in the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock worth $35,000 after acquiring an additional 105 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC bought a new position in Agilent Technologies in the third quarter worth approximately $38,000.

Agilent Technologies Stock Performance

Shares of A opened at $126.64 on Thursday. The company has a current ratio of 2.20, a quick ratio of 1.66 and a debt-to-equity ratio of 0.56. The company has a market capitalization of $36.11 billion, a price-to-earnings ratio of 29.11, a PEG ratio of 3.45 and a beta of 1.11. The stock has a 50 day moving average of $140.03 and a 200 day moving average of $138.87. Agilent Technologies, Inc. has a 12 month low of $121.45 and a 12 month high of $155.35.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The business had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. As a group, sell-side analysts forecast that Agilent Technologies, Inc. will post 5.57 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be given a $0.248 dividend. This represents a $0.99 annualized dividend and a dividend yield of 0.78%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.76%.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the transaction, the chief executive officer now directly owns 39,652 shares in the company, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on A shares. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Citigroup raised their target price on Agilent Technologies to $165.00 and gave the company a “buy” rating in a report on Thursday, December 19th. Bank of America dropped their target price on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a report on Friday, December 13th. Robert W. Baird dropped their target price on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a report on Thursday, February 27th. Finally, JPMorgan Chase & Co. dropped their target price on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday, November 26th. Seven research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and an average price target of $146.15.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.